Sunday, December 21, 2025
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Fiinews
No Result
View All Result
Home Manufacturing

India urged to be a world leader in pharma supplies

Fiinews by Fiinews
March 25, 2020
in Manufacturing
Reading Time: 2 mins read
A A
0
Pfizer
0
SHARES
10
VIEWS
LinkedinShare on Twitter

Threat of over dependence on China, warns Sridhar

India needs to be a World leader for not just Generic formulations but APIs (active pharmaceutical ingredients) too, according to S Sridhar, Chair, FICCI Pharmaceuticals Committee and MD, Pfizer.

India’s pharmaceutical import dependence on China, nearly 70% by value, has become a significant threat to the local healthcare manufacturing and global supply chain, Sridhar warned in a message welcoming the Government’s decision on Bulk Drug Parks.

While Indian pharma companies over years have climbed up the value chain to focus on value-added formulations, but this over dependence on China has increased the threat to the nation’s health security as some of these critical and complex APIs are crucial to address India’s growing disease burden.

India should not look at these Bulk Drug Parks only for Domestic requirement. China became big supplier because of scale which looked into both domestic and export requirement, he pointed out.

“Domestic (market) will not give scale and is always exposed to cost and pricing pressures. With this new policy initiative, the Government must look at incentivising the manufacturing of the critical 54 APIs which were recently restricted for exports,” he said on 22 Mar 2020.

He called on the Government and the Industry to work together for not just domestic capacities but fulfilling global export demands too.

The Indian pharma industry has been a world leader in generics markets contributing significantly to the global demand for generics in terms of volume.

‘Made in India’ drugs supplied to the developed economies such as the US, EU, Japan and many other countries are known for their safety and quality, he noted.

The Government is promoting Bulk Drug Parks for financing Common Infrastructure facilities in 3 Bulk Drug Parks with financial implication of Rs.3,000 crore over next 5 years to boost domestic manufacturing of critical KSMs/Drug Intermediates and APIs.

Welcoming the Government decision, he assured wide support from FICCI and its pharma member companies. fiinews.com

Tags: FICCIPfizer
ShareTweetShare

Related Posts

PIB
Manufacturing

Manufacturing: TDB supports Sodium-Ion project

by Fiinews
December 21, 2025
0
13

Advanced materials critical for energy storage systems, says Pathak The Technology Development Board (TDB), Department of Science & Technology (DST),...

Aarti industries logo
Manufacturing

Manufacturing: AIL secure Methanol-Toluene supply

by Fiinews
December 20, 2025
0
12

Kotecha’s strategy is to secure reliable access to critical feedstocks Aarti Industries Limited (AIL), a leading Indian speciality chemicals company,...

Gigabyte

Manufacturing: GIGABYTE starts production in India

December 19, 2025
12
Thales

Manufacturing: SFO secure contract from Thales

December 18, 2025
47
PIB

Manufacturing: Railways produced 4,224 LHB coaches

December 15, 2025
14
NIFTEM

Manufacturing: 170 PLISFPI applications approved

December 14, 2025
13
SBI YONO

POPULAR NEWS

  • Cristina Dnv

    Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Market: Indian-origin UGF scales heritage consumer brands globally

    0 shares
    Share 0 Tweet 0
  • Technologies: Royal Diamond sponsors aerspace Industries’ drones in UAE

    0 shares
    Share 0 Tweet 0
  • Investments: Foreign investors see India as long-term destination for fund placings

    0 shares
    Share 0 Tweet 0
  • Markets: Blue Dart maintains positive outlook on India

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Tender: Rail network to improve in suburb Mumbai
  • Manufacturing: TDB supports Sodium-Ion project
  • Export: JTIC to strengthen bilateral trade
  • Tenders: NPG evaluates 7 rail-1 road projects
  • Market: Singapore has long-term intent on India

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2024 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports

© 2024 FIINEWS - Design and developed by 7clicksmedia.